Investigation for the prevalence of anti-SARS-CoV-2 antibody.
Not Applicable
- Conditions
- COVID-19
- Registration Number
- JPRN-UMIN000046246
- Lead Sponsor
- Fukuoka City Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 281
Inclusion Criteria
Not provided
Exclusion Criteria
None
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The influence of post-vaccination reactions and use of antipyretic medications on the anti-SARS-CoV-2 spike antibody titer
- Secondary Outcome Measures
Name Time Method